These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 3619502)

  • 1. [In vivo antiaggregant activity of dihydroergotoxine].
    Manzanares J; Zaragozá F; Benedí J; Iglesias I
    Arch Farmacol Toxicol; 1986; 12(2-3):139-44. PubMed ID: 3619502
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L; Vilageliu J; Freixes J
    Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dihydroergocryptine constricts the vascular system of rats by the mediation of postsynaptic alpha-2-adrenoreceptors].
    Roquebert J
    Ann Pharm Fr; 1987; 45(4):343-6. PubMed ID: 2833147
    [No Abstract]   [Full Text] [Related]  

  • 4. Dissociation between hemodynamic and platelet antiaggregant effects of prostacyclin in dogs determined with a rapid platelet isolation technique.
    Czer GT; Moser KM
    J Lab Clin Med; 1983 Jul; 102(1):133-9. PubMed ID: 6343535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of dihydroergotoxine on platelet aggregation in rabbits.
    Markwardt F; Glusa E; Barthel W
    Thromb Res; 1977 Jun; 10(6):783-9. PubMed ID: 882965
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of platelet aggregation by Redergin (in vitro study).
    Stegnar M; Accetto B; Sket D
    Acta Med Iugosl; 1979; 33(2):129-37. PubMed ID: 506791
    [No Abstract]   [Full Text] [Related]  

  • 7. Prostaglandin H2/thromboxane A2 pathway in platelet aggregation and activity of Dahl salt-sensitive rat--a sulotroban study.
    Somova L
    Methods Find Exp Clin Pharmacol; 1996 Jun; 18(5):309-13. PubMed ID: 8817465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydergine, bencyclane and isoxsuprine on the rabbit platelet aggregation.
    Takano S; Sato K; Nemoto H; Suzuki T
    Fukushima J Med Sci; 1982 Dec; 29(1-2):19-23. PubMed ID: 7186874
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood level of dihydroergotoxine and inhibition of platelet aggregation.
    Markwardt F; Glusa E; Barthel W
    Thromb Res; 1978 May; 12(5):943-6. PubMed ID: 675595
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacologic activity of dihydroergotoxine methanesulfonate and its constituents].
    Palamara G; De Luca G; Materazzi M
    Boll Chim Farm; 1978 May; 117(5):289-95. PubMed ID: 743377
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ticlopidine as something more than a platelet antiaggregant].
    Villaverde C; Cánovas M; Padró T; Navarro C
    Arch Farmacol Toxicol; 1984 Aug; 10(2):121-32. PubMed ID: 6517621
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of a new benzofuran derivative on circulatory system of experimental animals.
    Woyke M; Kadłubowska D; Samochowiec L; Wójcicki J
    Pol J Pharmacol Pharm; 1981; 33(2):161-5. PubMed ID: 7312717
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibition of platelet aggregation and prevention of endotoxin-induced DIC by a protease inhibitor, FUT-175, in rats].
    Yoshikawa T; Murakami M; Furukawa Y; Onodera H; Yoshida N; Ueda M; Kato H; Takemura S; Sugino S; Kondo M
    Masui; 1984 Apr; 33(4):397-402. PubMed ID: 6471360
    [No Abstract]   [Full Text] [Related]  

  • 14. Adrenaline/PAF acether synergism on human platelets: involvement of Hydergine.
    Fouque F; Vargaftig BB
    J Pharmacol; 1985; 16 Suppl 3():129-34. PubMed ID: 4094442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of ethanol on ADP and collagen-induced platelet aggregation.
    Bengmark S; Elmér O; Göransson G; Zoucas E
    Thromb Haemost; 1981 Dec; 46(4):673-5. PubMed ID: 7330816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of changes in dietary prostaglandin precursor fatty acids on arterial blood pressure and vascular prostacyclin synthesis.
    Düsing R; Scherhag R; Glänzer K; Budde U; Kramer HJ
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():209-15. PubMed ID: 6221595
    [No Abstract]   [Full Text] [Related]  

  • 17. The ergoloid mesylate dihydroergotoxine: radioimmunoassay measurements on plasma and blood-pressure-lowering activity.
    Woodcock BG; Habedank WD; Loh W; Rietbrock N
    J Cardiovasc Pharmacol; 1984; 6(3):543-5. PubMed ID: 6202984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo anti-platelet properties of anipamil, a calcium channel blocker, in the rabbit.
    Osborne JA; Darius H; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):167-78. PubMed ID: 3715198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of voluntary ethanol intake in rats by a combination of dihydroergotoxine and thioridazine.
    Fadda F; Franch F; Mosca E; Meloni R; Gessa GL
    Alcohol Drug Res; 1987; 7(4):285-90. PubMed ID: 3828005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of N'-morpholinomethylurea derivatives with platelet antiaggregant activity.
    Ribalta JM; Artús JJ; Salvador L; Roma E; Vilageliu J; Freixes J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1782-6. PubMed ID: 6797442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.